Dyspnea in COPD: New Mechanistic Insights and Management Implications

被引:153
|
作者
O'Donnell, Denis E. [1 ,2 ]
Milne, Kathryn M. [1 ,2 ,3 ]
James, Matthew D. [1 ,2 ]
de Torres, Juan Pablo [2 ,4 ]
Neder, J. Alberto [2 ,4 ]
机构
[1] Kingston Hlth Sci Ctr, Dept Med, Div Respirol, Resp Invest Unit, Kingston, ON, Canada
[2] Queens Univ, Kingston, ON, Canada
[3] Univ British Columbia, Dept Med, Clinician Investigator Program, Vancouver, BC, Canada
[4] Kingston Hlth Sci Ctr, Dept Med, Div Respirol, Kingston, ON, Canada
基金
加拿大健康研究院;
关键词
COPD; Dyspnea; Respiratory physiology; OBSTRUCTIVE PULMONARY-DISEASE; AMERICAN THORACIC SOCIETY; OPIOID DRUG-USE; NEURAL RESPIRATORY DRIVE; EXERTIONAL DYSPNEA; EXERCISE ENDURANCE; GAS-EXCHANGE; OLDER-ADULTS; DYNAMIC HYPERINFLATION; LUNG HYPERINFLATION;
D O I
10.1007/s12325-019-01128-9
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Dyspnea is the most common symptom experienced by patients with chronic obstructive pulmonary disease (COPD). To avoid exertional dyspnea, many patients adopt a sedentary lifestyle which predictably leads to extensive skeletal muscle deconditioning, social isolation, and its negative psychological sequalae. This "dyspnea spiral" is well documented and it is no surprise that alleviation of this distressing symptom has become a key objective highlighted across COPD guidelines. In reality, this important goal is often difficult to achieve, and successful symptom management awaits a clearer understanding of the underlying mechanisms of dyspnea and how these can be therapeutically manipulated for the patients' benefit. Current theoretical constructs of the origins of activity-related dyspnea generally endorse the classical demand-capacity imbalance theory. Thus, it is believed that disruption of the normally harmonious relationship between inspiratory neural drive (IND) to breathe and the simultaneous dynamic response of the respiratory system fundamentally shapes the expression of respiratory discomfort in COPD. Sadly, the symptom of dyspnea cannot be eliminated in patients with advanced COPD with relatively fixed pathophysiological impairment. However, there is evidence that effective symptom palliation is possible for many. Interventions that reduce IND, without compromising alveolar ventilation (V-A), or that improve respiratory mechanics and muscle function, or that address the affective dimension, achieve measurable benefits. A common final pathway of dyspnea relief and improved exercise tolerance across the range of therapeutic interventions (bronchodilators, exercise training, ambulatory oxygen, inspiratory muscle training, and opiate medications) is reduced neuromechanical dissociation of the respiratory system. These interventions, singly and in combination, partially restore more harmonious matching of excessive IND to ventilatory output achieved. In this review we propose, on the basis of a thorough review of the recent literature, that effective dyspnea amelioration requires combined interventions and a structured multidisciplinary approach, carefully tailored to meet the specific needs of the individual.
引用
收藏
页码:41 / 60
页数:20
相关论文
共 50 条
  • [1] Dyspnea in COPD: New Mechanistic Insights and Management Implications
    Denis E. O’Donnell
    Kathryn M. Milne
    Matthew D. James
    Juan Pablo de Torres
    J. Alberto Neder
    Advances in Therapy, 2020, 37 : 41 - 60
  • [2] Refractory Dyspnea in Advanced COPD: New Insights and Novel Interventions
    Rocker, Graeme M.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2012, 43 (02) : 418 - 418
  • [3] Clinical implications of new mechanistic insights into atopic dermatitis
    Leung, Donald Y. M.
    CURRENT OPINION IN PEDIATRICS, 2016, 28 (04) : 456 - 462
  • [4] On the Cusp of Innovation: Mechanistic Insights Into Aortic Regurgitation and Implications in Surgical Management
    Chedid El Helou, Michel
    Collier, Patrick H.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (09):
  • [5] Therapeutic potential of ketamine in management of epilepsy: Clinical implications and mechanistic insights
    Tan, Yunfei
    Hashimoto, Kenji
    ASIAN JOURNAL OF PSYCHIATRY, 2024, 101
  • [6] TREATMENT OF DYSPNEA IN COPD - A CONTROLLED CLINICAL-TRIAL OF DYSPNEA MANAGEMENT STRATEGIES
    SASSIDAMBRON, DE
    EAKIN, EG
    RIES, AL
    KAPLAN, RM
    CHEST, 1995, 107 (03) : 724 - 729
  • [7] New insights into the molecular basis of atrial fibrillation: mechanistic and therapeutic implications
    Dobrev, Dobromir
    Nattel, Stanley
    CARDIOVASCULAR RESEARCH, 2011, 89 (04) : 689 - 691
  • [8] IS NOT THE TREATMENT PROGRAM OF DYSPNEA MANAGEMENT STRATEGIES EFFECTIVE FOR COPD
    TERAMOTO, S
    FUKUCHI, Y
    CHEST, 1995, 108 (06) : 1773 - 1774
  • [9] Adiponectin: mechanistic insights and clinical implications
    Turer, A. T.
    Scherer, P. E.
    DIABETOLOGIA, 2012, 55 (09) : 2319 - 2326
  • [10] Adiponectin: mechanistic insights and clinical implications
    A. T. Turer
    P. E. Scherer
    Diabetologia, 2012, 55 : 2319 - 2326